Health Condition 1: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified
Conditions
Interventions
Intervention1: Rocuronium and Sugammadex group: Rocuronium (1.5mg/kg) intubation dose with maintenance dose of (0.15mg/kg) and reversal of sugammadex (2.0mg/kg). With the help of acceleromyography, ne
Sponsors
Prerna Nayan
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18 to 70 years, with ASA I to III undergoing elective MLS surgery.
Exclusion criteria
Exclusion criteria: 1. Difficult airway 2. Neuromuscular disorders that impair neuromuscular blockade 3. Significant renal dysfunction 4. History of malignant hyperthermia 5. History of allergies to narcotics, muscle relaxants or other medications used during anaesthesia 6. Pregnant and breastfeeding, post-natal patients or child-bearing age and 7. ASA 4 and above patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the emergence from general anesthesia between rocuronium and sugammadex with succinylcholine, cisatracurium and neostigmine among elective microlaryngeal surgeries in a tertiary care center in India during the year 2024.Timepoint: 1 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the surgical conditions during the microlaryngeal surgeries. To assess the adequacy of muscle relaxant during intubation conditions. To evaluate the possible intraoperative and immediate postoperative adverse events. Timepoint: 1 hour | — |
Countries
India
Contacts
Public ContactSathish Kumar D
Christian Medical College
Outcome results
None listed